| scholarly article | Q13442814 |
| P50 | author | Anna K. Nowak | Q40897391 |
| P2093 | author name string | M J McCoy | |
| R A Lake | |||
| P2860 | cites work | T cell homeostatic proliferation elicits effective antitumor autoimmunity | Q24553060 |
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion | Q28131654 | ||
| Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. | Q37236554 | ||
| Targeting the effector site with IFN-alphabeta-inducing TLR ligands reactivates tumor-resident CD8 T cell responses to eradicate established solid tumors | Q40022319 | ||
| Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways | Q40575783 | ||
| IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. | Q40618350 | ||
| Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells | Q44432115 | ||
| Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens. | Q46784439 | ||
| Infiltration of a mesothelioma by IFN-gamma-producing cells and tumor rejection after depletion of regulatory T cells | Q51919478 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2009-05-04 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Tissue Antigens | Q1573131 |
| P1476 | title | Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesothelioma | |
| P478 | volume | 74 |
| Q26775614 | Biologic therapy and gene therapy in the multimodality treatment of malignant pleural mesothelioma |
| Q35872350 | Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma |
| Q40365927 | Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma |
| Q38416306 | Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy |
| Q36101238 | The Role of Regulatory T Cells in Mesothelioma. |
| Q33781142 | What's the place of immunotherapy in malignant mesothelioma treatments? |
| Q35176037 | Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma |
Search more.